期刊文献+

消化系统肿瘤发生有丝分裂危象的研究进展

Research progress of mitotic catastrophe in digestive system tumors
下载PDF
导出
摘要 消化系统肿瘤占全球肿瘤发病率第一位,其发生与饮食、环境和遗传等多种因素有关,早期往往无特征性表现。目前公众对消化道早癌筛查意识不强,确诊时部分患者已为中晚期,失去手术机会,因此放、化疗成为中晚期消化系统肿瘤患者的希望。抑制肿瘤细胞增殖和促进其凋亡一直是肿瘤研究领域的热点问题。有丝分裂危象是一种内源性肿瘤抑制机制,是在有丝分裂期,细胞周期检查点异常或纺锤体结构损伤而造成细胞死亡的现象,与肿瘤增殖抑制密切相关,但是发生的分子生物学机制及相关信号通路尚不明确。本文就消化系统肿瘤细胞发生有丝分裂危象的分子生物学机制进行综述,为研究消化系统肿瘤的综合治疗提供理论依据。 Digestive system tumors rank first incidence in global,and their occurrence is caused by multiple factors such as diet,environment,geneticsetc,and there are often no characteristic manifestations in the early stage.At present,the public does not have a strong concept of screening for early gastrointestinal cancer.Some patients are in the middle or late stage when they are diagnosed,and they lose the opportunity of surgery.Therefore,radiotherapy and chemotherapy have become the hope for patients with advanced digestive system tumors.Inhibiting tumor cell proliferation and promoting its apoptosis have always been a hot issue in the field of tumor research.Mitotic catastrophe is an endogenous tumor suppressive mechanism,which is a phenomenon of cell death caused by abnormal cell cycle checkpoints or damage to the spindle structure during mitosis.It is closely related to the inhibition of tumor cell proliferation,but its molecular biological mechanism and related signaling pathway are still unclear.This article reviews the molecular biological mechanism of mitotic catastrophe in digestive system tumor cells,and provides theoretical basis for the study of comprehensive treatment of digestive system tumors.
作者 李原(综述) 张玲(审校) LI Yuan;ZHANG Ling(Baotou Clinical Medical College of Inner Mongolia University,Baotou 014040,China)
出处 《实用肿瘤学杂志》 CAS 2022年第4期356-359,共4页 Practical Oncology Journal
基金 内蒙古医科大学科技百万工程联合项目(编号:YKD2018KJBW(LH)083)。
关键词 有丝分裂危象 消化系统肿瘤 分子机制 Mitotic catastrophe Digestive system tumors Molecular mechanism
  • 相关文献

参考文献2

二级参考文献68

  • 1Xiao-Ting Jiang, Hou-Quan Tao and Shou-Chun Zou Clinical Medical Laboratory and Depart-ment of Surgery , Zhejiang Provincial People’ sHospital, Hangzhou 310014 , China.Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer[J].Hepatobiliary & Pancreatic Diseases International,2004,3(3):464-468. 被引量:35
  • 2Abby L Mulkeen,Peter S Yoo,Charles Cha.Less common neoplasms of the pancreas[J].World Journal of Gastroenterology,2006,12(20):3180-3185. 被引量:24
  • 3Tao Wang Fu-Zhou Tian Zhong-Hong Cai Xu Li Tao Cheng Li Shi Qi Cheng.Ultrasonic interventional analgesia in pancreatic carcinoma with chemical destruction of celiac ganglion[J].World Journal of Gastroenterology,2006,12(20):3288-3291. 被引量:7
  • 4Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, RebeloM, Parkin DM, Forman D, Bray F. Cancer incidence and mortalityworldwide: sources, methods and major patterns in GLOBOCAN2012. Int J Cancer 2015; 136: E359-E386 [PMID: 25220842 DOI:10.1002/ijc.29210].
  • 5Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Prediction ofcancer incidence and mortality in Korea, 2014. Cancer Res Treat 2014;46: 124-130 [PMID: 24851103 DOI: 10.4143/crt.2014.46.2.124].
  • 6van Steenbergen LN, Elferink MA, Krijnen P, Lemmens VE,Siesling S, Rutten HJ, Richel DJ, Karim-Kos HE, Coebergh JW.Improved survival of colon cancer due to improved treatment anddetection: a nationwide population-based study in The Netherlands1989-2006. Ann Oncol 2010; 21: 2206-2212 [PMID: 20439339DOI: 10.1093/annonc/mdq227].
  • 7Quaglia A, Tavilla A, Shack L, Brenner H, Janssen-Heijnen M,Allemani C, Colonna M, Grande E, Grosclaude P, Vercelli M. Thecancer survival gap between elderly and middle-aged patients inEurope is widening. Eur J Cancer 2009; 45: 1006-1016 [PMID:19121578 DOI: 10.1016/j.ejca.2008.11.028].
  • 8Surgery for colorectal cancer in elderly patients: a systematicreview. Colorectal Cancer Collaborative Group. Lancet 2000; 356:968-974 [PMID: 11041397 DOI: 10.1016/S0140-6736(00)02713-6].
  • 9Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF. Age,sex, and racial differences in the use of standard adjuvant therapyfor colorectal cancer. J Clin Oncol 2002; 20: 1192-1202 [PMID:11870160].
  • 10Sundararajan V, Mitra N, Jacobson JS, Grann VR, Heitjan DF,Neugut AI. Survival associated with 5-fluorouracil-based adjuvantchemotherapy among elderly patients with node-positive coloncancer. Ann Intern Med 2002; 136: 349-357 [PMID: 11874307DOI: 10.7326/0003-4819-136-5-200203050-00007].

共引文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部